Repligen: Barclays raises target price to $225 from $175
RGEN•Barclays raised its target price for Repligen to $225 from $175.
Related News
Franklin BSP Realty Trust schedules third-quarter 2026 earnings release, conference call
FBRT•
XPO, Inc.: Citigroup raises to buy from neutral; raises target price to $224 from $220
XPO•
Fortrea Holdings raised to overweight from equal-weight; target price raised to $23 from $22
FTRE•
Ocean Power Technologies names Victoria Hay interim CFO after Robert Powers exit
OPTT•
NewGenIvf Group to consolidate shares 1-for-4 on Oct. 12
NIVF•